- Home
- PAVM vs ICCM Comparison
PAVM vs ICCM Comparison
Compare PAVM & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PAVM | ICCM |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | United States | Israel |
| Employees | 41 | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.8M | 41.4M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | PAVM | ICCM |
|---|---|---|
| Price | $5.45 | $4.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $65.00 | $2.50 |
| AVG Volume (30 Days) | 9.6K | ★ 1.1M |
| Earning Date | 05-15-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $603.94 | $139.51 |
| Revenue Next Year | $33.16 | $75.66 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.21 | $0.13 |
| 52 Week High | $28.44 | $5.69 |
Technical Indicators
Market Signals| Indicator | PAVM | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 27.61 | 86.13 |
| Support Level | $0.34 | $0.56 |
| Resistance Level | $6.63 | N/A |
| Average True Range (ATR) | 0.33 | 0.20 |
| MACD | 0.01 | 0.46 |
| Stochastic Oscillator | 4.24 | 80.05 |
Price Performance
Historical ComparisonAbout PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.